Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice.

Míreanna comhchosúla

• The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice.
  de réir: Philippe Gallay, et al.
  Foilsithe / Cruthaithe: (2019-01-01)
• Kinetics of the HBV-specific CTL response
  de réir: Maini, M, et al.
  Foilsithe / Cruthaithe: (1999)
• The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice
  de réir: Xiao-Zhen Kang, et al.
  Foilsithe / Cruthaithe: (2018-07-01)
• Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis
  de réir: Minjing He, et al.
  Foilsithe / Cruthaithe: (2023-04-01)
• Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
  de réir: Hao Li, et al.
  Foilsithe / Cruthaithe: (2018-09-01)